Skip to main content
Mahlon Johnson, MD, Pathology, Rochester, NY, Strong Memorial Hospital of the University of Rochester

MahlonDJohnsonMD

Pathology Rochester, NY

Neuropathology, Anatomic Pathology, Clinical Pathology

Professor, Pathology & Laboratory Medicine, University of Rochester School of Medicine & Dentistry

Are you Dr. Johnson?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 31 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

  • Office

    601 Elmwood Ave Box 626
    The University Of Rochester Medical Center Path Dept
    Rochester, NY 14642
    Phone+1 585-276-3087
    Fax+1 585-273-1027
  • Is this information wrong?

Summary

  • Dr. Mahlon Johnson, MD is a board certified pathologist in Rochester, New York. He is currently licensed to practice medicine in New York and Tennessee. He is affiliated with Strong Memorial Hospital of the University of Rochester and is a Professor at University of Rochester School of Medicine & Dentistry.

Education & Training

  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterFellowship, Neuropathology, 1987 - 1989
  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterResidency, Pathology-Anatomic and Clinical, 1984 - 1989
  • University of Tennessee Health Science Center College of Medicine
    University of Tennessee Health Science Center College of MedicineClass of 1981

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 1981 - 2026
  • NY State Medical License
    NY State Medical License 2006 - 2025
  • American Board of Pathology Anatomic Pathology
  • American Board of Pathology Neuropathology

Publications & Presentations

PubMed

Press Mentions

  • Low-Grade Fibromyxoid Tumor of the Dura: A New Entity?
    Low-Grade Fibromyxoid Tumor of the Dura: A New Entity?February 18th, 2024

Hospital Affiliations